Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Aerosolized Plus Intravenous Colistin Compared With Intravenous Colistin for Adjunctive Treatment of Ventilator-associated Pneumonia Due to Pandrugs-resistant Acinetobacter Baumannii in the Neonates: Randomized Controlled Trial

NCT02806141 is registered in ClinicalTrials.gov with Hat Yai Medical Education Center as lead sponsor.

NCT NCT02806141
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02806141 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Aerosolized Plus Intravenous Colistin Compared With Intravenous Colistin for Adjunctive Treatment of Ventilator-associated Pneumonia Due to Pandrugs-resistant Acinetobacter Baumannii in the Neonates: Randomized Controlled Trial
Lead sponsor
Hat Yai Medical Education Center
Phase
Phase 3
Overall status
Terminated
Start date
September 30, 2016
Completion date
October 31, 2017
Enrollment
204 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colistin adverse reaction, infection due to multidrug resistant acinetobacter, infection resistant to multiple drugs, pneumonia, ventilator-associated